Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study

2003 ◽  
Vol 10 (1) ◽  
pp. 29-36 ◽  
Author(s):  
Morrie M. Gelfand ◽  
Michèle Moreau ◽  
Normand J. Ayotte ◽  
John R. Hilditch ◽  
Betty A. Wong ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Clinical Assessment ◽  
Hormone Replacement ◽  
Controlled Study

Hormone replacement therapy and the endometrium

2009 ◽  
Vol 15 (3) ◽  
pp. 134-138 ◽  
Author(s):  
S Daayana ◽  
C M Holland
Keyword(s):  
Quality Of Life ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Hormone Replacement ◽  
Symptom Relief ◽  
Careful Consideration ◽  
Age Group ◽  
Individual Woman

The life-expectancy for women has increased significantly in the 20th century, although the time of onset of menopause has not. Almost a third of a woman's life is now postmenopausal and therefore many postmenopausal women consider using hormone replacement therapy (HRT) to improve their quality of life. Most cases of endometrial carcinoma arise in postmenopausal women and this raises concern among patients and clinicians with regard to the safety of HRT in this age group. Whenever the use of HRT is considered, a careful consideration of the actual benefit in terms of symptom relief and quality of life must be balanced against the risks for each individual woman. This review discusses the effects of HRT on the endometrium and the evidence regarding HRT use and risk of endometrial cancer.

Sign in / Sign up

Export Citation Format

Share Document